Dangerous recurrence of arrhythmia following withdrawal of flecainide. 1990

I A Murdoch, and K A Priestley, and J M Parsons
Department of Paediatric Cardiology, Guy's Hospital, London, U.K.

UI MeSH Term Description Entries
D008297 Male Males
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004310 Double Outlet Right Ventricle Incomplete transposition of the great vessels in which both the AORTA and the PULMONARY ARTERY arise from the RIGHT VENTRICLE. The only outlet of the LEFT VENTRICLE is a large ventricular septal defect (VENTRICULAR SEPTAL DEFECTS or VSD). The various subtypes are classified by the location of the septal defect, such as subaortic, subpulmonary, or noncommitted. Taussig-Bing Anomaly,Double Outlet Right Ventricle, Noncommitted VSD,Double Outlet Right Ventricle, Subaortic VSD,Double Outlet Right Ventricle, Subpulmonary VSD,Double-Outlet Right Ventricle,Anomaly, Taussig-Bing,Double-Outlet Right Ventricles,Right Ventricle, Double-Outlet,Taussig Bing Anomaly,Ventricle, Double-Outlet Right
D005424 Flecainide A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS. Flecainide Acetate,Apocard,Flecadura,Flecainid-Isis,Flecainide Monoacetate,Flecainide Monoacetate, (+-)-Isomer,Flecainide Monoacetate, (R)-Isomer,Flecainide Monoacetate, (S)-Isomer,Flecainide, (R)-Isomer,Flecainide, (S)-Isomer,Flecainide, 5-HO-N-(6-oxo)-Derivative,Flecainide, 5-HO-N-(6-oxo)-Derivative, (+-)-Isomer,Flecatab,Flécaïne,R818,Tambocor,Flecainid Isis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance
D013617 Tachycardia, Supraventricular A generic expression for any tachycardia that originates above the BUNDLE OF HIS. Supraventricular Tachycardia,Supraventricular Tachycardias,Tachycardias, Supraventricular

Related Publications

I A Murdoch, and K A Priestley, and J M Parsons
February 1989, Biological psychiatry,
I A Murdoch, and K A Priestley, and J M Parsons
July 1986, The American journal of cardiology,
I A Murdoch, and K A Priestley, and J M Parsons
March 1988, Minerva medica,
I A Murdoch, and K A Priestley, and J M Parsons
June 1989, Lancet (London, England),
I A Murdoch, and K A Priestley, and J M Parsons
December 1980, Biological psychiatry,
I A Murdoch, and K A Priestley, and J M Parsons
January 1989, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
I A Murdoch, and K A Priestley, and J M Parsons
September 2021, JACC. Case reports,
I A Murdoch, and K A Priestley, and J M Parsons
January 2009, Pacing and clinical electrophysiology : PACE,
I A Murdoch, and K A Priestley, and J M Parsons
November 1993, Kokyu to junkan. Respiration & circulation,
I A Murdoch, and K A Priestley, and J M Parsons
March 1985, Giornale italiano di cardiologia,
Copied contents to your clipboard!